Argus moves artificial cornea closer to market
This article was originally published in Clinica
Executive Summary
Australian firm Argus Biomedical is pressing ahead with plans to launch an artificial cornea after acquiring exclusive commercialisation rights from the Lions Eye Institute of Western Australia.